HealthyDirect · GrowthFit for a long SIP
LIC MF Multi Cap Fund
LIC Mutual FundEquity Scheme - Multi Cap Fund4 years
The scheme seeks to generate long term capital appreciation by investing in a diversified portfolio of equity & equity related instruments across large cap, mid cap and small cap stocks.
- NAV
- 18.8023
- 29 Oct 2026
- 1Y
- +1.2%
- Trailing CAGR
- AUM
- ₹2,187.21 Cr
- 30 Sept 2026
- Volatility
- Medium
- 14.2% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Buy checklist
History depth
Watch
4.0 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.78% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -19.3%. Ask whether you can hold through a similar fall.
Vs category
Pass
100% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Mahesh Bendre · 0.2 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 32.3% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 19%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+1.2%
- 3Y+17.1%
- 5Yn/a
- 10Yn/a
- SI+17.1%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+6.0%
- 3Y+9.0%
- 5Yn/a
- 10Yn/a
- Since inception
- +17.1%
- Calendar-day CAGR
- Excess 1Y
- +1.6%
- Category median, same plan and option
- 3Y win rate
- +100%
- Windows beating the median
- 3Y percentile
- 100
- Vs comparable share classes
- SIP 3Y XIRR
- +9.0%
- Simulated monthly SIP
- Worst rolling 3Y
- +15.7%
- 245 daily-ending windows
- Median rolling 3Y
- +20.5%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -19.3%
- Worst peak-to-trough
- Current
- -6.6%
- Below last peak
- Current spell
- 59 days
- Days below latest peak
- Time below peak
- +82%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 10 days
- 63 recovered episodes
- Longest recovery
- 231 days
- Trough to prior peak
16 Dec 2024 – 17 Oct 2025
Trough 28 Feb 2025 · recovered in 231 days
-19.3%
3 Nov 2025 – 15 Jun 2026
Trough 31 Mar 2026 · recovered in 76 days
-14.8%
31 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-9.3%
1 Oct 2024 – 16 Dec 2024
Trough 13 Nov 2024 · recovered in 33 days
-8.7%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
100
Vs category
60
Consistency
92
Risk-adjusted
64
Drawdown
52
Mean
74
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 100% of rolling 3-year windows.
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 63 holdings · top 10 are 32.3%.
- Top 5
- 20.5%
- Top 10
- 32.3%
- Largest holding
- 7.3%
- Effective holdings
- 45.2
Repo
Unspecified
7.3%
Garware Hi-Tech Films Ltd
Materials
4.0%
ICICI Bank Ltd
Financial
3.3%
Avalon Technologies Ltd.
Industrials
3.0%
Kotak Mahindra Bank Ltd
Financial
2.9%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Bajaj Finserv Multi Cap Fund
Bajaj Finserv Mutual Fund
- 1Y
- +2.2%
- 3Y
- n/a
- Vol
- 13.9%
- Max DD
- -14.2%
- Sharpe
- 0.37
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
Caveat: Higher TER · Lower trailing returns
BANDHAN MULTI CAP FUND
Bandhan Mutual Fund
- 1Y
- -5.0%
- 3Y
- +12.0%
- Vol
- 13.3%
- Max DD
- -18.3%
- Sharpe
- 0.51
- 3Y win
- +57%
- Lower volatility
- Shallower drawdown
Caveat: Higher TER · Lower trailing returns
SBI MultiCap Fund
SBI Mutual Fund
- 1Y
- -6.7%
- 3Y
- +12.0%
- Vol
- 12.2%
- Max DD
- -15.1%
- Sharpe
- 0.49
- 3Y win
- +5%
- Lower volatility
- Shallower drawdown
Caveat: Higher TER · Lower trailing returns
Aditya Birla Sun Life Multi-Cap Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- +0.9%
- 3Y
- +14.0%
- Vol
- 14.0%
- Max DD
- -20.0%
- Sharpe
- 0.67
- 3Y win
- +16%
- Lower volatility
Caveat: Deeper drawdown · Higher TER · Lower trailing returns
Franklin India Multi Cap Fund
Franklin Templeton Mutual Fund
- 1Y
- -1.7%
- 3Y
- n/a
- Vol
- 15.1%
- Max DD
- -18.7%
- Sharpe
- -0.10
- 3Y win
- n/a
- Shallower drawdown
Caveat: Higher volatility · Higher TER · Lower trailing returns